次世代抗体市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00006412
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 181
Buy Now

次世代抗体市場は、2021 年の 54 億 6,841 万米ドルから 2028 年までに 120 億 5,013 万米ドルに達すると予想されています。 2021 年から 2028 年にかけて 11.9% の CAGR で成長すると推定されています。



次世代抗体は、従来のモノクローナル抗体よりも特異性が高く、多くの場合強力になるように設計されています。次世代の抗体戦略は、抗体、ペイロード、リンカー、結合方法を組み合わせた有用な治療法を設計すると同時に、安定性、標的送達、限定的なオフターゲット効果を確保するために必要です。



このレポートは、次世代抗体市場の洞察と詳細な分析を提供し、市場動向、技術の進歩、市場ダイナミクス、世界中の主要な市場プレーヤーの競争状況分析などのさまざまなパラメーターを強調しています。また、COVID-19 パンデミックがすべての地域の市場に与える影響も含まれています。パンデミックは、世界中のさまざまな国の社会経済状況を混乱させています。最近のWHOの統計によると、現在、米国はCOVID-19の発生により世界で最も影響を受けた国であり、確認された症例数と死亡者数が世界中で最も多い.多数の COVID-19 陽性症例は、世界経済に悪影響を及ぼしています。全体的なビジネス活動の低下と、世界中で活動しているさまざまな業界の成長が見られます。



戦略的洞察



COVID-19アウトブレイクは、米国、カナダ、メキシコの医療インフラに多大な負担をかけています。さらに、ほとんどの製薬会社およびバイオテクノロジー企業と研究機関は、COVID-19 のワクチンと薬の開発に取り組んでいます。セットの製薬会社と小規模な新興企業の両方が、新しいコロナウイルスによって引き起こされた感染症を標的とする治療法とワクチンを進歩させるために前進しています。その結果、製薬会社やバイオテクノロジー会社、研究センター、教育研究機関におけるワクチン関連の研究活動は不可欠であると認識されており、主に業務や成果に影響を与えていません。しかし、研究活動の増加により、分析のための資金の入手可能性と、次世代抗体を含む抗体の必要性の両方が高まることが予想されます。さらに、COVID-19 の発生に先立ち、世界中の多くの研究者が、COVID-19 を発症するウイルスである SARS-CoV-2 のウイルス検査に関与しています。ワクチンと治療薬の両方について、生成された抗体は、標的ウイルスを相殺するための機能効率について調べられます。したがって、COVID-19 のパンデミックは、今後数年間で次世代抗体市場にプラスの影響を与えると予想されます。



地域に基づいて、次世代抗体市場は北部に分割されます。アメリカ、ヨーロッパ、アジア太平洋、中東とアフリカ、中南米.



次世代抗体市場の有利な地域



市場の洞察



次世代抗体市場を牽引する次世代抗体治療薬の需要の高まり



バイオテクノロジーの発展自己免疫疾患、炎症性疾患、および慢性疾患の治療での使用を促進している次世代抗体治療薬の受け入れが増加しています。次世代の抗体治療は、抗体薬物複合体 (ADC)、糖操作抗体、特異的抗体 (BsAbs) などの抗体治療における高度な技術の応用から生まれました。したがって、次世代抗体のアプリケーションは、がん、HIV、感染症などのさまざまな慢性疾患を治療するために広く研究されています。これらの抗体に対する需要の高まりにより、ADC やその他の次世代抗体の承認が急速に増加しています。治療学。たとえば、2020 年 5 月、武田薬品工業株式会社は、FDA 承認の検査で検出された未分化リンパ腫キナーゼ陽性 (ALK+) 転移性非小細胞肺癌 (NSCLC) の成人患者に対する ALUNBRIG (ブリガチニブ) の FDA 承認を発表しました。 . ALUNBRIG の現在の適応症は、その承認を得て、ファーストライン設定を含むように拡大されました。 ALUNBRIG は、ALK 分子異常を標的とするように設計された次世代のチロシンキナーゼ阻害剤 (TKI) です。同様に、2019 年に Genentech は、再発性または難治性のびまん性大細胞型 B 細胞性リンパ腫の成人患者に対するベンダムスチンおよびリツキシマブ製品との併用が適応となる CD79b 指向の抗体薬物複合体である Polatuzumab vedotin-piiq の FDA による迅速承認を発表しました。



したがって、次世代抗体市場は、臨床試験承認の増加と、さまざまな疾患の治療のための次世代抗体治療薬の高い採用により、予測期間中に急速に成長すると予想されます。



治療領域ベースの洞察



治療領域に基づいて、次世代抗体市場は腫瘍学と自己免疫または炎症に分岐します.オンコロジー セグメントは、市場の大きなシェアを占めています。



次世代抗体市場、2021 年および 2028 年の治療領域別



テクノロジーに基づく洞察



テクノロジーに基づいて、次世代抗体市場は、抗体薬物複合体、二重特異性抗体、Fc 改変抗体、抗体フラグメントと抗体様タンパク質、およびバイオシミラー抗体製品に分割されます。抗体薬物複合体セグメントは 2021 年に市場で最大のシェアを占め、同じセグメントは予測期間中に市場で 12.1% という最高の CAGR を記録すると推定されています。



次世代の抗体市場のプレーヤーは、製品の発売や拡大など、さまざまな有機的戦略を採用して、フットプリントと製品ポートフォリオを世界中に拡大し、高まる需要に対応しています。



会社概要< /h3>


  1. F.ホフマン・ラ・ロッシュ株式会社

  2. 協和キリン株式会社

  3. シーゲン株式会社

  4. イムノジェン株式会社
  5. 武田薬品工業株式会社

  6. アムジェン社

  7. ファイザー社

  8. キャタレント社

  9. アストラゼネカ

  10. Xencor



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the potential market for next-generation antibodies in terms of the region?

The Asia Pacific registered as the fastest-growing region in the global next-generation antibody market. The market in this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by growing investments from international players in China and India, improving government support in countries such as China, expanding R&D, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the next-generation antibody market players to grow during the forecast period.

What are the drivers and restraints for the next-generation antibody market?

The growth of the market is attributed to the increasing prevalence of cancer and growing demand for next-generation antibody therapeutics drives the market growth. However, the complications associated with the manufacturing and approvals hampers the market growth.

Who are the key players in the next-generation antibody market?

The disposable pipettes tips market majorly consists of players like F. HOFFMANN-LA ROCHE LTD., Kyowa Kirin Co., Ltd., Seagen Inc., ImmunoGen, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Pfizer Inc., Catalent Inc, AstraZeneca, and Xencor among others.

Which is the therapeutic area where the next-generation antibodies are often used?

The next-generation antibodies are used in the therapeutic areas- oncology and oncology, and autoimmune or inflammatory. Mostly, the next-generation antibodies are used in the oncology field. The oncology segment is likely to hold the largest share of the market in 2021. Moreover, the oncology segment is anticipated to register the highest CAGR in the market during the forecast period, due to the vast usage of next-generation antibodies for cancers, high volume consumption, and product innovation for this field

What is the market CAGR value of the next-generation antibody market during the forecast period?

The global next-generation antibody market is expected to reach US$ 5,428.41 million in 2028 from US$ 12,050.13 million in 2021. The market is estimated to grow with a CAGR of 11.9% from 2021-2028.

The List of Companies - Next-generation Antibody Market

  1. F. HOFFMANN-LA ROCHE LTD.      
  2. Kyowa Kirin Co., Ltd.         
  3. Seagen Inc.           
  4. ImmunoGen, Inc.              
  5. Takeda Pharmaceutical Company Limited               
  6. Amgen Inc.           
  7. Pfizer Inc.              
  8. Catalent Inc          
  9. AstraZeneca         
  10. Xencor

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports